GlassScriptPhysician profile
Garrett C Koon
NPI 1366821746
$2,378.60
in general payments reported to CMS, 2019-2025
19 companies · $256 in 2025
The $256 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $312 · 2021: $378 · 2022: $396 · 2023: $481 · 2024: $314 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Travel and Lodging: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.59 |
| Travel and Lodging | $110.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $817.54 | 2021-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $290.16 | 2019-2022 | |
| Davol INC. | $201.03 | 2020-2023 | Phasix Mesh |
| Ironshore Pharmaceuticals INC. | $145.53 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $138.29 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $108.88 | 2019-2024 | |
| Endogastric Solutions, INC | $108.00 | 2022 | |
| Becton, Dickinson and Company | $87.91 | 2023 | Phasix Mesh |
| Tris Pharma INC | $87.55 | 2021-2024 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $85.02 | 2020-2021 | |
| Neos Therapeutics, LP | $83.83 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $65.04 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $56.44 | 2019-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sobi, INC | $27.40 | 2022-2023 | |
| Shire North American Group INC | $17.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $16.95 | 2019 | |
| Sanofi Pasteur INC. | $15.44 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.58 | 2021 | |
| Adlon Therapeutics L.P. | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Koon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.